Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Tatva Chintan Pharma Chem has informed that it enclosed the transcript of the earnings call held on 16 May 2026 post announcement of financial results of the Company for the quarter and financial year ended 31 March 2026. The above information shall be made available on Company’s website of at www.tatvachintan.com.
The above information is a part of company’s filings submitted to BSE.
